Fig. 2
From: Investigating PPT2’s role in ovarian cancer prognosis and immunotherapy outcomes
The expression of PPT2 in OC. (A) The comparison of PPT2 mRNA expression in 45 OC tissues and 9 normal ovary tissues. (B)The comparison of the PPT2 mRNA expression between the OC tissues and normal tissues in the TCGA and GTEx datasets. (C-F) The comparison of PPT2 protein in OC tissues and normal ovary tissues in datasets GSE27651, GSE29450, GSE40995, and GSE51088, respectively. (G)The comparison of PPT2 expression in pan-cancer tissues and normal tissues. * p < 0.05, ** p < 0.01, and *** p < 0.001. (H) The IHC of normal and OC tissues